Hi there, we see you're using OS, why not try our app?
Skip to main content

Therapeutic apheresis

These specialist services remove harmful, disease-forming proteins, chemicals, or cells from patients’ blood

Life-saving patient care

Therapeutic Apheresis is one of our flagship services, and the only one that deals with patients directly. We treat over 1,200 adults and children every year from eight dedicated therapeutic units across the country. Find out more.

Patient Experience Survey 2019

Therapeutic Apheresis Services (TAS) is dedicated to continual improvement. Patient and donor feedback is very important in helping us to identify how we can improve any aspects of our service and the care our patients, donors and their families receive during their visit.

Help us to make improvements by completing our Patient Experience Survey between Friday 22nd November and Saturday 21st December 2019. The survey is open to carers as well as patients.

Please follow one of the links below to take part in either the adult or paediatric version of the survey. If a patient is not able to complete the survey themselves we suggest an adult/carer complete the survey on their behalf.

TAS Patient Experience Survey 2019 (Adult)

TAS Patient Experience Survey 2019 (Paediatric)

You're in safe hands

  • Our facilities are regulated by the Care Quality Commission, Human Tissue Authority and the Joint Accreditation Committee - ISCT (Europe) & EBMT (JACIE)
  • We have a longstanding exemplary regulatory performance history
  • Each of our units are co-located in NHS Trust environments to provide continuity of care and access to clinical support services

You may also be interested in